Van ECK Associates Corp bought a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 26,608 shares of the company's stock, valued at approximately $475,000. Van ECK Associates Corp owned 0.08% of Grail as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently made changes to their positions in GRAL. abrdn plc purchased a new stake in shares of Grail during the fourth quarter worth approximately $3,768,000. Douglas Lane & Associates LLC purchased a new stake in shares of Grail during the fourth quarter worth approximately $3,034,000. Slow Capital Inc. purchased a new stake in shares of Grail during the fourth quarter worth approximately $2,379,000. 180 Wealth Advisors LLC purchased a new stake in shares of Grail during the fourth quarter worth approximately $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new position in Grail in the fourth quarter valued at approximately $559,000.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on GRAL shares. Wolfe Research started coverage on Grail in a report on Friday, November 15th. They issued a "peer perform" rating for the company. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price target for the company.
Check Out Our Latest Report on Grail
Grail Stock Performance
GRAL traded up $4.57 on Monday, reaching $45.30. The company's stock had a trading volume of 2,054,427 shares, compared to its average volume of 1,517,779. The stock has a 50 day moving average of $26.69 and a two-hundred day moving average of $19.25. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.
Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.
Grail Profile
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Articles
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
